Cargando…
Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
OBJECTIVE: There is no conclusive evidence to suggest vitamin D level can prevent or treat infection with the new coronavirus disease 2019. This study aimed to investigate the effects of serum level of vitamin D in patients with coronavirus disease 2019 on death, severity, and hospitalization durati...
Autores principales: | Dana, Nasim, Nasirian, Maryam, Vaseghi, Golnaz, Heshmat-Ghahdarijani, Kiyan, Ataei, Behrooz, Mosayebi, Azam, Manteghinejad, Amirreza, Haghjooy Javanmard, Shaghayegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atatürk University School of Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797700/ https://www.ncbi.nlm.nih.gov/pubmed/35950827 http://dx.doi.org/10.5152/eurasianjmed.2022.21088 |
Ejemplares similares
-
Co-infection between the severe acute respiratory syndrome coronavirus 2 and the influenza Type B in Isfahan, Iran
por: Heshmat-Ghahdarijani, Kiyan, et al.
Publicado: (2021) -
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
por: Haghjooy Javanmard, Shaghayegh, et al.
Publicado: (2020) -
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020) -
Red Blood Cell Distribution Width (RDW) as a Predictor of In-Hospital Mortality in COVID-19 Patients; a Cross Sectional Study
por: Jandaghian, Setareh, et al.
Publicado: (2021) -
Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia
por: Vaseghi, Golnaz, et al.
Publicado: (2022)